Michael D Quartermain1, Sara K Pasquali2, Kevin D Hill3, David J Goldberg4, James C Huhta5, Jeffrey P Jacobs6, Marshall L Jacobs7, Sunghee Kim8, Ross M Ungerleider9. 1. Departments of Pediatrics, and mquarter@wakehealth.edu. 2. Department of Pediatrics and Communicable Diseases, University of Michigan C.S. Mott Children's Hospital, Ann Arbor, Michigan; 3. Department of Pediatrics, Duke University Medical Center, Durham, North Carolina; 4. Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania; 5. Department of Perinatal Cardiology, Pediatrix Medical Group and. 6. Department of Surgery, All Children's Hospital and Johns Hopkins University, St Petersburg, Florida; 7. Division of Cardiac Surgery, Department of Surgery, Johns Hopkins School of Medicine, Baltimore, Maryland; and. 8. Duke Clinical Research Institute, Durham, North Carolina. 9. Cardiovascular and Thoracic Surgery, Wake Forest University School of Medicine, Winston-Salem, North Carolina;
Abstract
BACKGROUND AND OBJECTIVE: Prenatal diagnosis allows improved perioperative outcomes for fetuses with certain forms of congenital heart disease (CHD). Variability in prenatal diagnosis has been demonstrated in other countries, leading to efforts to improve fetal imaging protocols and access to care, but has not been examined across the United States. The objective was to evaluate national variation in prenatal detection across geographic region and defect type in neonates and infants with CHD undergoing heart surgery. METHODS: Cardiovascular operations performed in patients ≤6 months of age in the United States and included in the Society of Thoracic Surgeons Congenital Heart Surgery Database (2006-2012) were eligible for inclusion. Centers with >15% missing prenatal diagnosis data were excluded from the study. Prenatal diagnosis rates were compared across geographic location of residence and defect type using the χ(2) test. RESULTS: Overall, the study included 31,374 patients from 91 Society of Thoracic Surgeons Congenital Heart Surgery Database participating centers across the United States. Prenatal detection occurred in 34% and increased every year, from 26% (2006) to 42% (2012). There was significant geographic variation in rates of prenatal diagnosis across states (range 11.8%-53.4%, P < .0001). Significant variability by defect type was also observed, with higher rates for lesions identifiable on 4-chamber view than for those requiring outflow tract visualization (57% vs 32%, P < .0001). CONCLUSIONS: Rates of prenatal CHD detection in the United States remain low for patients undergoing surgical intervention, with significant variability between states and across defect type. Additional studies are needed to identify reasons for this variation and the potential impact on patient outcomes.
BACKGROUND AND OBJECTIVE: Prenatal diagnosis allows improved perioperative outcomes for fetuses with certain forms of congenital heart disease (CHD). Variability in prenatal diagnosis has been demonstrated in other countries, leading to efforts to improve fetal imaging protocols and access to care, but has not been examined across the United States. The objective was to evaluate national variation in prenatal detection across geographic region and defect type in neonates and infants with CHD undergoing heart surgery. METHODS: Cardiovascular operations performed in patients ≤6 months of age in the United States and included in the Society of Thoracic Surgeons Congenital Heart Surgery Database (2006-2012) were eligible for inclusion. Centers with >15% missing prenatal diagnosis data were excluded from the study. Prenatal diagnosis rates were compared across geographic location of residence and defect type using the χ(2) test. RESULTS: Overall, the study included 31,374 patients from 91 Society of Thoracic Surgeons Congenital Heart Surgery Database participating centers across the United States. Prenatal detection occurred in 34% and increased every year, from 26% (2006) to 42% (2012). There was significant geographic variation in rates of prenatal diagnosis across states (range 11.8%-53.4%, P < .0001). Significant variability by defect type was also observed, with higher rates for lesions identifiable on 4-chamber view than for those requiring outflow tract visualization (57% vs 32%, P < .0001). CONCLUSIONS: Rates of prenatal CHD detection in the United States remain low for patients undergoing surgical intervention, with significant variability between states and across defect type. Additional studies are needed to identify reasons for this variation and the potential impact on patient outcomes.
Authors: Marshall L Jacobs; Megan Daniel; Constantine Mavroudis; David L S Morales; Jeffrey P Jacobs; Charles D Fraser; Joseph W Turek; John E Mayer; Christo Tchervenkov; John Conte Journal: Ann Thorac Surg Date: 2011-08 Impact factor: 4.330
Authors: J S Carvalho; L D Allan; R Chaoui; J A Copel; G R DeVore; K Hecher; W Lee; H Munoz; D Paladini; B Tutschek; S Yagel Journal: Ultrasound Obstet Gynecol Date: 2013-03 Impact factor: 7.299
Authors: Patricia A Boyd; Ann M Tonks; Judith Rankin; Catherine Rounding; Diana Wellesley; Elizabeth S Draper Journal: J Med Screen Date: 2011 Impact factor: 2.136
Authors: J Rychik; A Szwast; S Natarajan; M Quartermain; D D Donaghue; J Combs; J W Gaynor; P J Gruber; T L Spray; M Bebbington; M P Johnson Journal: Ultrasound Obstet Gynecol Date: 2010-10 Impact factor: 7.299
Authors: Sean M O'Brien; David R Clarke; Jeffrey P Jacobs; Marshall L Jacobs; Francois G Lacour-Gayet; Christian Pizarro; Karl F Welke; Bohdan Maruszewski; Zdzislaw Tobota; Weldon J Miller; Leslie Hamilton; Eric D Peterson; Constantine Mavroudis; Fred H Edwards Journal: J Thorac Cardiovasc Surg Date: 2009-11 Impact factor: 5.209
Authors: Sinai C Zyblewski; Elizabeth G Hill; Girish Shirali; Andrew Atz; Geoffrey Forbus; Javier Gonzalez; Anthony Hlavacek Journal: Pediatr Cardiol Date: 2009-08-25 Impact factor: 1.655
Authors: Michael J Walsh; George R Verghese; M Eric Ferguson; Nora F Fino; David J Goldberg; Sonal T Owens; Nelangi Pinto; Sinai C Zyblewski; Michael D Quartermain Journal: Pediatr Cardiol Date: 2017-03-27 Impact factor: 1.655
Authors: Matthew J Campbell; William O Quarshie; Jennifer Faerber; David J Goldberg; Christopher E Mascio; Joshua J Blinder Journal: Pediatr Cardiol Date: 2020-02-27 Impact factor: 1.655
Authors: Erica Sood; Allison Karpyn; Abigail C Demianczyk; Jennie Ryan; Emily A Delaplane; Trent Neely; Aisha H Frazier; Anne E Kazak Journal: Pediatr Crit Care Med Date: 2018-07 Impact factor: 3.624
Authors: Daniel A Castellanos; Keila N Lopez; Jason L Salemi; Alireza A Shamshirsaz; Yunfei Wang; Shaine A Morris Journal: J Pediatr Date: 2020-07 Impact factor: 4.406
Authors: Guihua Jiang; Todd J Herron; Julie Di Bernardo; Kendal A Walker; K Sue O'Shea; Shaun M Kunisaki Journal: Stem Cells Transl Med Date: 2016-07-27 Impact factor: 6.940